This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Fremes, S. E. Articles by Lichtenstein, S. V. Search for Related Content PubMed PubMed Citation Articles by Fremes, S. E. Articles by Lichtenstein, S. V. Pubmed/NCBI databases Medline Plus Health Information Coronary Artery Bypass Surgery Related Collections CV surgery: coronary artery disease

(Circulation. 2000;102:III-339.)
© 2000 American Heart Association, Inc.

Myocardial Protection and Vascular Biology

Late Results of the Warm Heart Trial

The Influence of Nonfatal Cardiac Events on Late Survival

Stephen E. Fremes, MD; Miguel G. Tamariz, MD; Dan Abramov, MD; George T. Christakis, MD; Jeri Y. Sever; Kathy Sykora, MSc; Bernard S. Goldman, MD; Christopher M. S. Feindel, MD; Samuel V. Lichtenstein, MD, PhD

From the Divisions of Cardiovascular Surgery of Sunnybrook and Women’s College Health Sciences Centre, St Paul’s Hospital, Toronto General Hospital, Toronto, Onatario, Canada, and Institute for Clinical Evaluative Sciences.

Background—The Warm Heart Trial randomized 1732 CABG patients to receive warm or cold blood cardioplegia. In the warm cardioplegia patients, nonfatal perioperative cardiac events were significantly decreased and the mortality rate was nonsignificantly decreased (1.4% versus 2.5%, P=0.12). The purpose of the present study was to evaluate the late results of these trial patients.

Methods and Results—Randomization was stratified according to surgeon and urgency of the operation. Seven hundred sixty-two patients recruited from 1 of the centers were followed through the hospital clinic for late events. Late survival (including perioperative deaths) at 72 months was nonsignificantly greater in the warm cardioplegia patients (94.5±1.7%, mean±SEM) than in the cold cardioplegia patients (90.9±2.6%). Independent predictors of mortality by Cox proportional hazards model were redo CABG, diabetes mellitus, renal insufficiency, and increasing age. The influence of nonfatal perioperative events (perioperative myocardial infarction according to computerized ECG readings or low output syndrome as determined by an outcome committee) on late survival was also analyzed. Late survival at 84 months was significantly reduced in the group who experienced nonfatal perioperative outcomes (94.5±1.7% versus 84.9±4.5%, P<0.001) and remained a significant predictor after adjustment for other important variables (risk ratio 6.4, 95% CI 1.87 to 8.73, P<0.0001).

Conclusions—Effective myocardial protection through either cold or warm blood cardioplegia is essential, because late survival is significantly reduced in patients with nonfatal perioperative cardiac outcomes.

Key Words: bypass • cardioplegia • complications • survival • trials